Biotechnology

Calysta Energy(TM) Targets Natural Gas as Advantaged Feedstock for Transportation Fuels and Chemicals

Calysta Energy(TM), a new company, today announced it has been established to use natural gas, an advantaged feedstock, to develop new liquid transportation fuels and high value chemicals that are cost-effective, scalable and reduce environmental impact. Current technology approaches to creating new fuels and chemicals have failed to achieve necessary market economics, creating a significant …

Calysta Energy(TM) Targets Natural Gas as Advantaged Feedstock for Transportation Fuels and Chemicals Read More »

Research and Markets: Competing in the Global Coagulation Testing Market 2013

This comprehensive seven-country report is designed to help current suppliers and potential market entrants identify and evaluate major business opportunities emerging in the coagulation market during the next five years. The report explores business and technological trends in the US, five major European countries (France, Germany, Italy, Spain, UK) and Japan; provides estimates of the …

Research and Markets: Competing in the Global Coagulation Testing Market 2013 Read More »

Acorda Provides Financial and Pipeline Update for First Quarter 2016

“We are well into our transition from a single-product company to a well-diversified biopharmaceutical enterprise, focused on developing therapies to benefit patients with neurological conditions across multiple disease states, including multiple sclerosis, Parkinson’s disease, stroke, migraine and epilepsy,” said Ron Cohen, M.D., Acorda’s President and CEO. “Through our business development activities and advancement of our …

Acorda Provides Financial and Pipeline Update for First Quarter 2016 Read More »

Aduro Biotech”s Personalized LADD Therapy Featured in an Oral Presentation at SITC”s New Cancer Immunotherapy Agents in Development Program

LADD is Aduro’s proprietary platform of live, attenuated double-deleted Listeria monocytogenes strains that have been engineered to express tumor-associated antigens to induce an innate immune response and tumor-specific T cell-mediated immunity. Personalized LADD, or pLADD, is a second generation LADD technology that is being designed for individualized, patient-specific immunotherapy. The pLADD approach leverages the immune …

Aduro Biotech”s Personalized LADD Therapy Featured in an Oral Presentation at SITC”s New Cancer Immunotherapy Agents in Development Program Read More »

True North Appoints Biotechnology Commercial Executive Jeff Ajer to its Board of Directors

True North Therapeutics, a clinical stage biotechnology company developing novel product candidates that selectively inhibit the Complement system, today announced that the company has appointed Jeff Ajer, Executive Vice President and Chief Commercial Officer of BioMarin, as an independent director to the company’s board of directors. With more than 20 years of experience building industry-leading …

True North Appoints Biotechnology Commercial Executive Jeff Ajer to its Board of Directors Read More »

Blood Glucose Test Strip Market Analysis by Company Profile, Technology, Latest Trend & Foresight to 2022

Blood glucose test strips market is expected to reach US$ 18.5 billion by 2020, and the market is projected to grow at a CAGR of ~ 6.2 % during the forecast period 2015-2020. It has been segmented into thick film electrochemical, thin film electrochemical, and optical. Market scenario Blood glucose test strip is a small …

Blood Glucose Test Strip Market Analysis by Company Profile, Technology, Latest Trend & Foresight to 2022 Read More »

RxCelerate Acquires Specialist Bioanalytical CRO Total Scientific Ltd.

The outsourced drug development companyRxCelerate Ltd. announced today that it has completed the acquisition of Cambridge-based specialist bioanalytical contract research organisationTotal Scientific Ltd. RxCelerate, which has offices in Cambridge, Massachusetts, and Cambridge, U.K., provides bespoke drug development services to clients ranging from virtual biotech companies to global pharmaceutical giants.Its unique model is built around outsourcing …

RxCelerate Acquires Specialist Bioanalytical CRO Total Scientific Ltd. Read More »

X4 Pharmaceuticals Appoints Gary J. Bridger, PhD, to Board of Directors

“X4 and its board of directors will benefit from the appointment of Gary Bridger, a well-respected innovator and scientific leader,” said Mike Wyzga, chair of the Board of Directors for X4 Pharmaceuticals. “Gary’s contribution to the high growth and success of many biotechnology companies, including AnorMED, is well recognized. We will leverage Gary’s experience as …

X4 Pharmaceuticals Appoints Gary J. Bridger, PhD, to Board of Directors Read More »

Cell Therapeutics, Inc. (CTI) Reports 2008 Fourth Quarter and Year End Financial Results

Net operating expenses decreased by 33% in 2008; Forecast cutting net operating expenses by approximately 50% in 2009 CTI expects to complete pixantrone NDA submission in Q2 2009 In addition, given the current credit crunch most biotech companies must operate in today, its Board of Directors is engaged in an evaluation of short- and long-term …

Cell Therapeutics, Inc. (CTI) Reports 2008 Fourth Quarter and Year End Financial Results Read More »

Clickatell Honored With Idea and Innovation Award by the San Jose/Silicon Valley Business Journal

The event was held at the Computer History Museum in Mountain View, and featured winners from biotech, software, hardware and consumer products. “The goal of the Idea and Innovation Awards was to recognize some of the most innovative products and people here in Silicon Valley,” said publisher James MacGregor. “Several of the honorees have achieved …

Clickatell Honored With Idea and Innovation Award by the San Jose/Silicon Valley Business Journal Read More »

EFT BioTech Holdings Reports 10,000 to Attend Taiwan Affiliate Rally Events

Following a successful series of events in Vietnam earlier this month, EFTExecutives will hold a series of rallies in Taiwan to both recruit newmembers and reward top EFT Chinese affiliate leaders. “Live evententhusiasm, new products and education are of paramount importance to theorganic growth of EFT. This is what fuels our business expansion effortsand translates …

EFT BioTech Holdings Reports 10,000 to Attend Taiwan Affiliate Rally Events Read More »

Pressure BioSciences, Inc. to Present at the Biotech Showcase 2011 and the OneMedPlace Financial Forum 2011 Investor Conferences

Pressure BioSciences, Inc. (PBI) is a NASDAQ Capital Markets listed company focused on the development and sale of instrumentation and consumables based on a novel, enabling technology platform called Pressure Cycling Technology (PCT).PCT uses cycles of hydrostatic pressure between ambient and ultra-high levels (up to 35,000 psi and greater) to control bio-molecular interactions.PBI currently holds …

Pressure BioSciences, Inc. to Present at the Biotech Showcase 2011 and the OneMedPlace Financial Forum 2011 Investor Conferences Read More »

KannaLife Sciences, Inc. Announces Creation of South Park Pharmaceuticals

WEST HILLS, N.Y., Aug. 13, 2013 (GLOBE NEWSWIRE) — KannaLife Sciences, Inc. (“KannaLife”) and Biotech Inc. (“Biotech”), 50/50 joint venture partners of South Park Ventures, LLC announced today, the creation of South Park Pharmaceuticals, Inc. (“SPPI”), a pharmaceutical company established for the purpose of developing, testing, marketing and selling botanical medicaments, naturopathic compounds and phyto-medical …

KannaLife Sciences, Inc. Announces Creation of South Park Pharmaceuticals Read More »

Forbion Announces Closing of Initial Public Offering of Portfolio Company arGEN-X

Forbion Capital Partners, the leading Dutch Venture Capital firm investing in world-class healthcare technologies, is proud to announce that its portfolio company arGEN-X N.V. (arGEN-X or the company), a clinical-stage biopharmaceutical company focused on creating and developing differentiated therapeutic antibodies for the treatment of cancer and severe autoimmune diseases, has successfully completed its Initial Public …

Forbion Announces Closing of Initial Public Offering of Portfolio Company arGEN-X Read More »

Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) to Ring The Nasdaq Stock Market Closing Bell

Thursday, September 10, 2015 – 3:45 p.m. to 4:00 p.m. ET or Fiber Line (Encompass Waterfront): 4463 Alexion is a global biopharmaceutical company focused on developing and delivering life-transforming therapies for patients with devastating and rare disorders. Alexion developed and commercializes Soliris(R) (eculizumab), the first and only approved complement inhibitor to treat patients with paroxysmal …

Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) to Ring The Nasdaq Stock Market Closing Bell Read More »

Senesco Announces Start of Cohort 3 in Phase 1b/2a Study in Multiple Myeloma and Non-Hodgkins B-Cell Lymphoma

Senesco Technologies, Inc. (“Senesco” or the “Company”) (OTC QB: SNTI) reported today that the Data Review Committee (DRC) for its SNS01-T trial in multiple myeloma and non-Hodgkins B-cell lymphoma approved initiating cohort 3 and escalating the SNS01-T dose level four-fold to 0.2 mg/Kg. The DRC’s review of the results of cohort 2 concluded that SNS01-T …

Senesco Announces Start of Cohort 3 in Phase 1b/2a Study in Multiple Myeloma and Non-Hodgkins B-Cell Lymphoma Read More »

Feed Phytogenics Market (Phytogenic Feed Additives Market) Size to exceed USD 740 Million by 2022: Global Market Insights, Inc.

Essential oil-based products dominated feed phytogenics market share and accounted for over 40% of the total volume in 2014, with consumption exceeding 50 kilo tons in 2014. They are majorly used in swine production for effective weight gain applications. Herbs & spices are likely to attain growth rates at 2.9% up to 2022. Lack in …

Feed Phytogenics Market (Phytogenic Feed Additives Market) Size to exceed USD 740 Million by 2022: Global Market Insights, Inc. Read More »

Newly Updated Transdermal Drug Delivery Report 2016: Focus on Technologies, Markets, and Companies 2015-2025 – Research and Markets

The market for transdermal drug delivery is analyzed according to technologies and therapeutic areas from 2015 to 2025. This report deals with transdermal drug delivery – an approach used to deliver drugs through the skin for therapeutic use as an alternative to oral,intravascular, subcutaneous and transmucosal routes. Various transdermal drug delivery technologies are described including …

Newly Updated Transdermal Drug Delivery Report 2016: Focus on Technologies, Markets, and Companies 2015-2025 – Research and Markets Read More »

Cardiovascular Drug Delivery Report 2016-2017 & 2026: Technologies, Markets and Companies – 82 Companies & 80 Collaborations – Research and Markets

Drug delivery to the cardiovascular system is different from delivery to other systems because of the anatomy and physiology of the vascular system; it supplies blood and nutrients to all organs of the body. Drugs can be introduced into the vascular system for systemic effects or targeted to an organ via the regional blood supply. …

Cardiovascular Drug Delivery Report 2016-2017 & 2026: Technologies, Markets and Companies – 82 Companies & 80 Collaborations – Research and Markets Read More »

Accomplished BioPharma Executive Mina Sooch Joins BioVie Board of Directors and Purchases Company Stock

Mina has been recognized as a business leader with awards such as “Dealmaker of the Year” in 2016 and 2014 by Crain’s Detroit and “Entrepreneur of the Year” in 2015 by MVCA. Prior to her CEO roles, she spent over a decade in life sciences venture capital as a Founder of Apjohn Ventures with several …

Accomplished BioPharma Executive Mina Sooch Joins BioVie Board of Directors and Purchases Company Stock Read More »

Disrupt SF “18 super early bird prices disappear in three days

We’re still finalizing our list of speakers, but here’s a prime example. Anne Wojcicki, co-founder of 23andMe, and John Riccitiello of Unity will be joining us. Wojcicki’s an expert at pivoting and navigating the tricky waters of regulatory approval. And, according to DFJ Growth partner Barry Schuler, an investor in Unity, Riccitiello’s mobile gaming software …

Disrupt SF “18 super early bird prices disappear in three days Read More »

AlgaEnergy and Yokogawa Sign Strategic Partnership & Equity Agreement to Accelerate Growth of the Microalgae Biotech Sector

AlgaEnergy, a Spanish biotechnology company specializing in the production and commercial applications of microalgae, and Yokogawa Electric Corporation (TOKYO:6841), a leading provider of industrial automation, control, and measurement technology, announce the signing of a partnership & equity participation agreement. The strategic agreement involves an approximately 10 million euro investment by Yokogawa to acquire newly issued …

AlgaEnergy and Yokogawa Sign Strategic Partnership & Equity Agreement to Accelerate Growth of the Microalgae Biotech Sector Read More »

Genzyme Canada Inc.: Single Injection Approved in Canada for Treatment of OA of the Knee

MISSISSAUGA, ONTARIO — (Marketwire) — 03/16/09 — Following the February 2009 approval by Health Canada, Genzyme Canada today announced the availability of Synvisc-One(TM) (Hylan GF-20), a single injection viscosupplement approved for Osteoarthritis (OA) of the knee. Synvisc-One is the latest addition to a growing Synvisc(R) family of products used to treat Osteoarthritis including: a single …

Genzyme Canada Inc.: Single Injection Approved in Canada for Treatment of OA of the Knee Read More »

University of Louisville Takes First Place at Cincom Hosted Spirit of Enterprise Competitions

The University of Cincinnati received first runner-up, the University of Oregon earned second runner-up and the University of Florida took home the top prize in the Taxi/Limo Round. The Spirit of Enterprise, hosted and sponsored by Cincom, is an invitational forum for next generation entrepreneurs to “road test” business-venture concepts — ideas that may have …

University of Louisville Takes First Place at Cincom Hosted Spirit of Enterprise Competitions Read More »

MolSofts New Technology Brings Online Publications to Life in Fully Interactive 3D

SAN DIEGO, Oct. 26 /PRNewswire/ — Scientific publishing is now going 3D. For the first time in online publishing history, the PLoS ONE journal is publishing original research papers containing fully annotated and interactive 3D objects. This 3D environment provides a “movie-like” experience but with a significant difference – the reader is in control of …

MolSofts New Technology Brings Online Publications to Life in Fully Interactive 3D Read More »

Pharma Industry Leaders to Reveal Hottest, Latest Trends for Pharma & Biotech at Groundbreaking Event

The Pharma Market Research Conference is your EXCLUSIVE ENTRY into the world of pharmaceutical market research. This is the most important and impactful event in pharmaceutical market research. Nowhere else will you find the industry’s best and brightest all under one roof! See what exciting innovations and solutions are being offered by 2011’s premier sponsors/exhibitors, …

Pharma Industry Leaders to Reveal Hottest, Latest Trends for Pharma & Biotech at Groundbreaking Event Read More »

Are Major League Growth Hormone Testing Agreements Nothing More Than Hot Air?

No matter which side of the controversy you’re on, one thing is certain: Growth Factor-9 is selling like hotcakes. The product’s exclusive distributors, GNC, Lucky Vitamin, and The Vitamin Shoppe, are having trouble keeping it in stock. Still, some skeptics are saying it sounds too good to be true. So, is there a catch? Actually, …

Are Major League Growth Hormone Testing Agreements Nothing More Than Hot Air? Read More »